» Articles » PMID: 10680973

Selective Delivery of Adriamycin to a Solid Tumor Using a Polymeric Micelle Carrier System

Overview
Journal J Drug Target
Publisher Informa Healthcare
Date 2000 Feb 19
PMID 10680973
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The anticancer drug, adriamycin (ADR), was incorporated by physical entrapment into polymeric micelles for selective delivery to a murine solid tumor colon adenocarcinoma 26 (C 26). In vivo antitumor activity of ADR was greatly enhanced by this incorporation into polymeric micelles. Using one polymeric micelle delivery system, the tumor completely disappeared at two doses, while free ADR exhibited a fair inhibition effect on tumor growth only at the maximum tolerated dose. Biodistribution analysis revealed that the physically entrapped micellar ADR accumulated at tumor sites in a highly selective manner. These results indicate that these polymeric micelles are a promising system for delivering hydrophobic anticancer drugs selectively to solid tumor sites using a passive targeting mechanism.

Citing Articles

Photo Irradiation-Induced Core Crosslinked Poly(ethylene glycol)-block-poly(aspartic acid) Micelles: Optimization of Block Copolymer Synthesis and Characterization of Core Crosslinked Micelles.

Shiraishi K, Yusa S, Ito M, Nakai K, Yokoyama M Polymers (Basel). 2019; 9(12).

PMID: 30966010 PMC: 6418968. DOI: 10.3390/polym9120710.


Polymeric Micelles of Biodegradable Diblock Copolymers: Enhanced Encapsulation of Hydrophobic Drugs.

Hussein Y, Youssry M Materials (Basel). 2018; 11(5).

PMID: 29702593 PMC: 5978065. DOI: 10.3390/ma11050688.


Self-assembling prodrugs.

Cheetham A, Chakroun R, Ma W, Cui H Chem Soc Rev. 2017; 46(21):6638-6663.

PMID: 29019492 PMC: 5844511. DOI: 10.1039/c7cs00521k.


Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization.

Ramasamy T, Choi J, Cho H, Umadevi S, Shin B, Choi H Pharm Res. 2014; 32(6):1947-56.

PMID: 25471199 DOI: 10.1007/s11095-014-1588-8.


Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.

Dawidczyk C, Russell L, Searson P Front Chem. 2014; 2:69.

PMID: 25202689 PMC: 4142601. DOI: 10.3389/fchem.2014.00069.